Celebrating Excellence in Pharmacy: Schondelmeyer's 2025 Award Recognition
The American Pharmacists Association (APhA) has proudly announced that Dr. Stephen W. Schondelmeyer, a prominent figure in the field of pharmacy, is set to receive the esteemed Remington Honor Medal in 2025. This award is part of the APhA Awards and Honors Program, which is recognized as the most comprehensive recognition initiative within the pharmacy profession. The official announcement of various award recipients will unfold over the coming weeks, culminating with the formal recognition of all honorees during the APhA Annual Meeting Exposition, scheduled to take place in Nashville, Tennessee from March 21 – 24, 2025.
Named after the renowned community pharmacist, educator, and manufacturer Joseph P. Remington, this award has been a hallmark of excellence since its establishment in 1918. It honors outstanding services rendered to American pharmacy, either recently or over an extended period marked by significant contributions.
Dr. Schondelmeyer, who hails from Minneapolis, Minnesota, boasts over 50 years of research experience that has notably enhanced access to and affordability of prescription drugs. He has played a key role in fostering competition in drug pricing, developing managing drug benefit plans, and improving reimbursement processes. Furthermore, his efforts have included analyzing workforce trends and pharmacists' compensation while advocating for policies aimed at reducing drug shortages and bolstering drug supply resilience.
Currently serving as a professor of Pharmaceutical Economics at the University of Minnesota, Dr. Schondelmeyer is the creator and Director of the PRIME Institute, where he spearheads economic and public policy research focused on the roles of pharmacists and pharmaceuticals in society. His rich background spans clinical practice, academia, and influential positions within professional associations, as well as state and federal government roles.
Dr. Schondelmeyer’s impactful work has significantly influenced medication and health policy, as acknowledged by his nominators. His dedication to increasing awareness about the pharmacy profession and the vital roles pharmacists play in enhancing medication distribution is unparalleled. His notable contributions include 930 invited presentations, 260 scientifically peer-reviewed publications, and extensive engagement with legislative bodies, including Congress and state legislatures.
In addition to his extensive research and advocacy efforts, Dr. Schondelmeyer has earned a multitude of accolades throughout his career. He is a recipient of APhA's Hubert H. Humphrey Award and has been honored with the Tyler Prize for stimulating research. His achievements also include the Hall of Distinguished Alumni Lifetime Achievement Award from the University of Kentucky College of Pharmacy, the Weaver Medal from the University of Minnesota College of Pharmacy, and the Leadership in Action Award from the Minnesota Health Action Group.
Dr. Schondelmeyer’s academic credentials are as impressive as his professional accomplishments. He earned his Bachelor of Science in Pharmacy from the University of Missouri-Kansas City in 1974, pursued an ASHP Residency at the University of Kentucky, and received a Doctor of Pharmacy in 1977. He later completed a master's in public administration (1979) and a PhD in pharmacy administration (1984) from The Ohio State University.
As the pharmacy profession and the community at large celebrate Dr. Schondelmeyer’s achievements, his receipt of the 2025 Remington Honor Medal is a testament to his substantial contributions to advancing pharmacy practice and policy, ensuring better healthcare outcomes for patients nationwide. This recognition not only honors Dr. Schondelmeyer’s past achievements but also inspires current and future pharmacists to pursue excellence in their practice.
In conclusion, the announcement of Dr. Schondelmeyer as the recipient of the Remington Honor Medal underscores the importance of commitment and innovation within the pharmacy sector. His legacy will undoubtedly continue to shape the future of pharmacy and the health policies that affect millions.
Named after the renowned community pharmacist, educator, and manufacturer Joseph P. Remington, this award has been a hallmark of excellence since its establishment in 1918. It honors outstanding services rendered to American pharmacy, either recently or over an extended period marked by significant contributions.
Dr. Schondelmeyer, who hails from Minneapolis, Minnesota, boasts over 50 years of research experience that has notably enhanced access to and affordability of prescription drugs. He has played a key role in fostering competition in drug pricing, developing managing drug benefit plans, and improving reimbursement processes. Furthermore, his efforts have included analyzing workforce trends and pharmacists' compensation while advocating for policies aimed at reducing drug shortages and bolstering drug supply resilience.
Currently serving as a professor of Pharmaceutical Economics at the University of Minnesota, Dr. Schondelmeyer is the creator and Director of the PRIME Institute, where he spearheads economic and public policy research focused on the roles of pharmacists and pharmaceuticals in society. His rich background spans clinical practice, academia, and influential positions within professional associations, as well as state and federal government roles.
Dr. Schondelmeyer’s impactful work has significantly influenced medication and health policy, as acknowledged by his nominators. His dedication to increasing awareness about the pharmacy profession and the vital roles pharmacists play in enhancing medication distribution is unparalleled. His notable contributions include 930 invited presentations, 260 scientifically peer-reviewed publications, and extensive engagement with legislative bodies, including Congress and state legislatures.
In addition to his extensive research and advocacy efforts, Dr. Schondelmeyer has earned a multitude of accolades throughout his career. He is a recipient of APhA's Hubert H. Humphrey Award and has been honored with the Tyler Prize for stimulating research. His achievements also include the Hall of Distinguished Alumni Lifetime Achievement Award from the University of Kentucky College of Pharmacy, the Weaver Medal from the University of Minnesota College of Pharmacy, and the Leadership in Action Award from the Minnesota Health Action Group.
Dr. Schondelmeyer’s academic credentials are as impressive as his professional accomplishments. He earned his Bachelor of Science in Pharmacy from the University of Missouri-Kansas City in 1974, pursued an ASHP Residency at the University of Kentucky, and received a Doctor of Pharmacy in 1977. He later completed a master's in public administration (1979) and a PhD in pharmacy administration (1984) from The Ohio State University.
As the pharmacy profession and the community at large celebrate Dr. Schondelmeyer’s achievements, his receipt of the 2025 Remington Honor Medal is a testament to his substantial contributions to advancing pharmacy practice and policy, ensuring better healthcare outcomes for patients nationwide. This recognition not only honors Dr. Schondelmeyer’s past achievements but also inspires current and future pharmacists to pursue excellence in their practice.
In conclusion, the announcement of Dr. Schondelmeyer as the recipient of the Remington Honor Medal underscores the importance of commitment and innovation within the pharmacy sector. His legacy will undoubtedly continue to shape the future of pharmacy and the health policies that affect millions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.